These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 9285608)

  • 1. Prospective assessment of continuous intrathecal infusion of baclofen for spasticity caused by acquired brain injury: a preliminary report.
    Meythaler JM; McCary A; Hadley MN
    J Neurosurg; 1997 Sep; 87(3):415-9. PubMed ID: 9285608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Case report of intrathecal baclofen administration in a child with severe spasticity attributable to traumatic brain injury].
    Matsuda R; Nishimura F; Hirabayashi H; Motoyama Y; Mishima H; Park YS; Nakase H; Sakaki T
    Brain Nerve; 2009 Mar; 61(3):313-5. PubMed ID: 19301603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of severe, disabling spasticity with continuous intrathecal baclofen therapy following acquired brain injury: the experience of a tertiary institution in Singapore.
    Wang ZM; Law JH; King NK; Rajeswaran DK; Soh S; Rao JP; Ng WH; Chua KS
    Singapore Med J; 2016 Jan; 57(1):8-12. PubMed ID: 26831310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathecally administered baclofen for treatment of children with spasticity of cerebral origin.
    Armstrong RW; Steinbok P; Cochrane DD; Kube SD; Fife SE; Farrell K
    J Neurosurg; 1997 Sep; 87(3):409-14. PubMed ID: 9285607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuously infused intrathecal baclofen for spastic/dystonic hemiplegia: a preliminary report.
    Meythaler JM; Guin-Renfroe S; Hadley MN
    Am J Phys Med Rehabil; 1999; 78(3):247-54. PubMed ID: 10340423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of clinical and neurophysiologic responses to intrathecal baclofen bolus administration in moderate-to-severe spasticity after acquired brain injury.
    Stokic DS; Yablon SA; Hayes A
    Arch Phys Med Rehabil; 2005 Sep; 86(9):1801-6. PubMed ID: 16181946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous intrathecal infusion of baclofen in patients with spasticity caused by spinal cord injuries.
    Korenkov AI; Niendorf WR; Darwish N; Glaeser E; Gaab MR
    Neurosurg Rev; 2002 Aug; 25(4):228-30. PubMed ID: 12172730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of intrathecal baclofen therapy on spasticity in patients with brain injury].
    Dénes Z; Klauber A; Both B; Lóránd E
    Ideggyogy Sz; 2012 Jul; 65(7-8):243-8; discussion 248. PubMed ID: 23074844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional outcome of intrathecal baclofen administration for severe spasticity.
    Boviatsis EJ; Kouyialis AT; Korfias S; Sakas DE
    Clin Neurol Neurosurg; 2005 Jun; 107(4):289-95. PubMed ID: 15885386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of cerebral origin spasticity with continuous intrathecal baclofen delivered via an implantable pump: long-term follow-up review of 18 patients.
    Rawicki B
    J Neurosurg; 1999 Nov; 91(5):733-6. PubMed ID: 10541228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intrathecal baclofen for treatment of spasticity in patient with cerebral palsy--a preliminary report].
    Jóźwiak M; Idzior M; Huber J; Szulc A; Grottel K
    Chir Narzadow Ruchu Ortop Pol; 2003; 68(4):253-9. PubMed ID: 14702678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timing of intrathecal baclofen therapy in persons with acquired brain injury: influence on outcome.
    Posteraro F; Calandriello B; Galli R; Logi F; Iardella L; Bordi L
    Brain Inj; 2013; 27(13-14):1671-5. PubMed ID: 24087852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Continuous intrathecal infusion of baclofen. A new therapeutic method for spasticity].
    Berg-Johnsen J; Røste GK; Solgaard T; Lundar T
    Tidsskr Nor Laegeforen; 1998 Sep; 118(21):3256-60. PubMed ID: 9772811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional benefits and cost/benefit analysis of continuous intrathecal baclofen infusion for the management of severe spasticity.
    Sampson FC; Hayward A; Evans G; Morton R; Collett B
    J Neurosurg; 2002 Jun; 96(6):1052-7. PubMed ID: 12066906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of early use of intrathecal baclofen therapy for treating spastic hypertonia due to acquired brain injury.
    Francisco GE; Hu MM; Boake C; Ivanhoe CB
    Brain Inj; 2005 May; 19(5):359-64. PubMed ID: 16094783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous intrathecal baclofen infusions. An introduction and overview.
    Kamensek J
    Axone; 1999 Mar; 20(3):67-72. PubMed ID: 10401268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term intrathecal Baclofen infusion in supraspinal spasticity of adulthood.
    Dario A; Di Stefano MG; Grossi A; Casagrande F; Bono G
    Acta Neurol Scand; 2002 Feb; 105(2):83-7. PubMed ID: 11903116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical study of intrathecal baclofen using a programmable pump for intractable spasticity.
    Guillaume D; Van Havenbergh A; Vloeberghs M; Vidal J; Roeste G
    Arch Phys Med Rehabil; 2005 Nov; 86(11):2165-71. PubMed ID: 16271565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An introduction to trialing intrathecal baclofen in patients with hemiparetic spasticity: a description of 3 cases.
    Harned ME; Salles SS; Grider JS
    Pain Physician; 2011; 14(5):483-9. PubMed ID: 21927053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrathecal baclofen for spasticity management: a comparative analysis of spasticity of spinal vs cortical origin.
    Saval A; Chiodo AE
    J Spinal Cord Med; 2010; 33(1):16-21. PubMed ID: 20397440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.